Europe's rising Ozempic trend meets simple tricks to curb cravings

More people in Europe are turning to GLP-1 medications like Ozempic and Wegovy to manage their weight. Over the past year, usage has climbed, especially among younger groups in Austria. But simple lifestyle changes, from exercise to distraction, can also help control cravings and appetite.

In the last twelve months, the number of adults using GLP-1 drugs has risen to 12%—a 6% increase since May 2022. These medications, including Semaglutide (Wegovy®) by Novo Nordisk, are becoming more common, particularly among adolescents in Austria. While official statistics remain limited, the trend is clear.

Beyond medication, small daily habits can make a difference. Drinking green or black tea may help burn fat and stabilise blood sugar levels. Staying hydrated also prevents the body from confusing thirst for hunger. Physical activity plays a key role too. Aerobic exercise boosts a peptide that naturally reduces appetite, rather than increasing hunger. Even simple actions like clenching a fist or tightening muscles can help resist cravings. Mental strategies work as well. Watching a funny video, calling a friend, or solving a puzzle can distract the mind long enough to let cravings pass. Focusing on forgiveness or doing good deeds also lowers stress, which in turn reduces emotional eating. The key is learning to tell the difference between real hunger and temporary cravings.

GLP-1 drugs are growing in popularity, but everyday techniques still offer effective ways to manage appetite. From exercise to hydration and distraction, these methods provide alternatives for those looking to control cravings without medication. The rise in drug use highlights the demand for solutions, but simple lifestyle adjustments remain accessible options.